Lareb: fixed drug eruptions to be added to doxycycline labelling News item 30 April 2016 Pages: 3 - 3
Comparable CVD risks with GLP-1 agonists vs other antidiabetics Clinical study 30 April 2016 Pages: 9 - 9
Proton pump inhibitors associated with serious renal outcomes Clinical study 30 April 2016 Pages: 11 - 11
Aclarubicin/cytarabine/granulocyte colony stimulating factors Case report 30 April 2016 Pages: 14 - 14